United States · FDA National Drug Code directory

Obagi Skintrinsiq Brightening Protocol

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 62032-905_2b80c4d4-9623-46b8-8993-8105b0a16f2a
Product NDC: 62032-905
Form: KIT
Composition / generic term: HOMOSALATE, OCTISALATE, AND ZINC OXIDE
Labeler: Obagi Cosmeceuticals LLC
Marketing category: OTC MONOGRAPH DRUG
Marketing start / end (source format): 20210801
Source listing expiry: 20261231

Source-listed ingredients

Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.

These values do not establish equivalence or a dose recommendation.

Packages

1 KIT in 1 BOX (62032-905-05) * 57 g in 1 BOTTLE, PLASTIC * 1 BOTTLE, PUMP in 1 CARTON / 48 g in 1 BOTTLE, PUMP * 1 TUBE in 1 CARTON (62032-140-09) / 85 g in 1 TUBE * 59 mL in 1 BOTTLE, PLASTIC * 60 mL in 1 BOTTLE, PLASTIC · 62032-905-05

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →